| Name | eCF309 |
|---|---|
| Synonyms |
2-Benzoxazolamine, 5-[4-amino-1-(2,2-diethoxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-
3-(2-Amino-1,3-benzoxazol-5-yl)-1-(2,2-diethoxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
| Description | eCF309 is a potent and highly selective mTOR inhibitor with remarkably low off-target activities (IC50 = 10-15 nM, both in vitro and in cells)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 642.5±65.0 °C at 760 mmHg |
| Molecular Formula | C18H21N7O3 |
| Molecular Weight | 383.404 |
| Flash Point | 342.4±34.3 °C |
| Exact Mass | 383.170593 |
| LogP | 2.31 |
| Appearance | solid |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.727 |
| Storage condition | Store at -20℃ |
| Water Solubility | Soluble in DMSO |